Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 30, 2006 10:49 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan's Collaborating Scientist to Become McGill's New Research Star

LAS VEGAS, Nov. 30, 2006 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce today that Dr. Vassilios Papadopoulos, the lead scientist...
November 21, 2006 10:06 ET | Source: Samaritan Pharmaceuticals, Inc.

United States Patent Application Published for Samaritan's Novel Alzheimer's Drug SP-04

LAS VEGAS, Nov. 21, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals, Inc. (AMEX:LIV) a developer of innovative drugs, announced today they received notice of the publication of its novel Alzheimer's...
November 16, 2006 11:01 ET | Source: Samaritan Pharmaceuticals, Inc.

Photo Release -- Samaritan Recognized for HIV Innovation

LAS VEGAS, Nov. 16, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. and Samaritan PharmaPlaz Ireland, Inc. (AMEX:LIV) a developer of innovative drugs, announced today it has been selected by the...
November 14, 2006 14:46 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Arrives at Definitive Agreement to Acquire Metastatin to Expand Cancer Pipeline

LAS VEGAS, Nov. 14, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, is pleased to announce today that Samaritan has reached a definitive agreement to...
November 13, 2006 11:04 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Receives AMEX Compliance Notice Letter

LAS VEGAS, Nov. 13, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) announced today, that on November 6, 2006, it received a notice from the American Stock Exchange, Inc. ("AMEX")...
November 06, 2006 09:12 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan Submits IND to FDA for Novel Anti-Amyloidal Alzheimer's Drug Candidate Caprospinol

LAS VEGAS, Nov. 6, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. and Samaritan Pharma Ireland, Inc. (AMEX:LIV) developers of innovative drugs, announced today it has submitted an Investigational...
November 03, 2006 10:27 ET | Source: Samaritan Pharmaceuticals, Inc.

International Patent Application Published for Samaritan's Novel Alzheimer's Drug Caprospinol

LAS VEGAS, Nov. 3, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV) a developer of innovative drugs, announced today we have received notice of the publication of its novel anti-amyloidal...
November 01, 2006 03:10 ET | Source: Samaritan Pharmaceuticals, Inc.

Photo Release -- Samaritan Completes Patient Enrollment in Proof of Concept PIIb Clinical Trial for HIV Entry Inhibitor Drug SP-01A

LAS VEGAS, Nov. 1, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today it has completed patient enrollment of its Phase IIb (Stage 2) 28 day...
October 03, 2006 09:30 ET | Source: Samaritan Pharmaceuticals, Inc.

Samaritan to Highlight Oral HIV Entry Inhibitor and Novel Alzheimer's Drug At BioPartnering Europe to Seek Partnering Opportunities

LAS VEGAS, Oct. 3, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today, it will highlight the uniqueness and advantages of its oral HIV...
September 19, 2006 10:39 ET | Source: Samaritan Pharmaceuticals, Inc.

Taglich Brothers Issues Updated Research Report On Samaritan Pharmaceuticals

LAS VEGAS, Sept. 19, 2006 (PRIMEZONE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today that Taglich Brothers published an updated Samaritan...